Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • AC Immune amends IPO

    AC Immune S.A., Lausanne, Switzerland Business: Neurology Date announced: 2016-06-15 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Credit Suisse; Jefferies; Leerink Partners Note: AC Immune amended …

    Published on 6/20/2016
  • Gemphire amends IPO

    Gemphire Therapeutics Inc., Northville, Mich. Business: Cardiovascular, Endocrine/Metabolic Date announced: 2016-06-13 Type: IPO To be raised: Up to $48.8 million Shares: 3.8 million Price: $11-$13 Underwriters: …

    Published on 6/20/2016
  • AiVita Biomedical completes venture financing

    AiVita Biomedical Inc., Irvine, Calif. Business: Gene/Cell therapy, Dermatology, Cancer Date completed: 2016-06-10 Type: Venture financing Raised: $2 million Investor: California Technology Ventures

    Published on 6/20/2016
  • Allecra completes venture financing

    Allecra Therapeutics GmbH, Lorrach, Germany Business: Infectious Date completed: 2016-06-15 Type: Venture financing Raised: EUR22 million ($24.8 million) Investors: Delos Capital; Forbion Capital Partners; Edmond de …

    Published on 6/20/2016
  • Alpine Immune Sciences completes venture financing

    Alpine Immune Sciences Inc., Seattle, Wash. Business: Cancer, Autoimmune, Infectious Date completed: 2016-06-13 Type: Venture financing Raised: $48 million Investors: OrbiMed Advisors; Frazier & Co.; Alpine BioVentures

    Published on 6/20/2016
  • Antibe Therapeutics completes private placement of units

    Antibe Therapeutics Inc. (TSX-V:ATE; OTCQX:ATBPF), Hamilton, Ontario Business: Neurology, Autoimmune, Endocrine/Metabolic Date completed: 2016-06-10 Type: Private placement of units Raised: C$968,500 ($758,142) Units: 9…

    Published on 6/20/2016
  • BioTime completes follow-on

    BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 2016-06-16 Type: Follow-on Raised: $17.5 million Shares: 7.3 million Price: $2.39 Shares after …

    Published on 6/20/2016
  • Blade Therapeutics completes venture financing

    Blade Therapeutics Inc., South San Francisco, Calif. Business: Pulmonary, Autoimmune Date completed: 2016-06-16 Type: Venture financing Raised: $45 million Investors: Deerfield Management; Pfizer Venture Investments; …

    Published on 6/20/2016
  • Celsion completes direct public offering

    Celsion Corp. (NASDAQ:CLSN; Tel Aviv:CLSN), Lawrenceville, N.J. Business: Drug delivery, Cancer, Cardiovascular Date completed: 2016-06-13 Type: Direct public offering Raised: $6 million Shares: 2.3 million Price: $1.36…

    Published on 6/20/2016
  • Champions Oncology completes follow-on

    Champions Oncology Inc. (NASDAQ:CSBR), Hackensack, N.J. Business: Cancer Date completed: 2016-06-09 Type: Follow-on Raised: $5.1 million Shares: 2.3 million Price: $2.25 Shares after offering: 11 million Underwriter: …

    Published on 6/20/2016
  • Cytori completes rights offering of units

    Cytori Therapeutics Inc. (NASDAQ:CYTX), San Diego, Calif. Business: Gene/Cell therapy, Autoimmune, Cardiovascular Date completed: 2016-06-15 Type: Rights offering of units Raised: $17.1 million Shares: 6.7 million Price…

    Published on 6/20/2016
  • GlycoMimetics completes follow-on

    GlycoMimetics Inc. (NASDAQ:GLYC), Rockville, Md. Business: Hematology, Cancer, Cardiovascular Date completed: 2016-06-17 Type: Follow-on Raised: $20.1 million Shares: 3.3 million Price: $6.10 Shares after offering: 22.7…

    Published on 6/20/2016
  • ImmunoGen completes private placement of senior convertible notes

    ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass. Business: Cancer Date completed: 2016-06-15 Type: Private placement of senior convertible notes Raised: $100 million Shares outstanding prior: 87.1 million Investor: …

    Published on 6/20/2016
  • Innocoll completes follow-on

    Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Business: Drug delivery, Infectious, Neurology Date completed: 2016-06-16 Type: Follow-on Raised: $40.1 million Shares: 5.7 million Price: $7 Shares after offering: …

    Published on 6/20/2016
  • Mersana completes venture financing

    Mersana Therapeutics Inc., Cambridge, Mass. Business: Cancer Date completed: 2016-06-16 Type: Venture financing Raised: $33 million Investors: Wellington Management; Cormorant Asset Management; Arrowpoint Partners; …

    Published on 6/20/2016
  • Minerva Neurosciences completes follow-on

    Minerva Neurosciences Inc. (NASDAQ:NERV), Cambridge, Mass. Business: Neurology Date completed: 2016-06-14 Type: Follow-on Raised: $50 million Shares: 5.3 million Price: $9.50 Shares after offering: 33.2 million …

    Published on 6/20/2016
  • Mount Tam completes private placement of convertible notes

    Mount Tam Biotechnologies Inc. (OTCBB:MNTM), Novato, Calif. Business: Autoimmune Date completed: 2016-06-14 Type: Private placement of convertible notes Raised: $5 million Shares outstanding prior: 43.2 million Investor…

    Published on 6/20/2016
  • NMD Pharma completes venture financing

    NMD Pharma ApS, Aarhus, Denmark Business: Neurology Date completed: 2016-06-13 Type: Venture financing Raised: $3 million Investors: Lundbeckfond Emerge; Novo Seeds; Capnova

    Published on 6/20/2016
  • Oasmia completes private placement of convertible notes

    Oasmia Pharmaceutical AB (SSE:OASM; NASDAQ:OASM), Uppsala, Sweden Business: Drug delivery, Veterinary, Cancer Date completed: 2016-06-10 Type: Private placement of convertible notes Raised: SEK42 million ($5.1 million) …

    Published on 6/20/2016
  • ProtoKinetix completes private placement

    ProtoKinetix Inc. (OTCQB:PKTX), West Vancouver, B.C. Business: Supply/Service, Inflammation, Transplant Date completed: 2016-06-16 Type: Private placement Raised: $166,000 Shares: 4.2 million Price: $0.04 Shares after …

    Published on 6/20/2016
  • Rgenix completes venture financing

    Rgenix Inc., New York, N.Y. Business: Cancer Date completed: 2016-06-15 Type: Venture financing Raised: $33 million Investors: Novo A/S; Sofinnova Partners; Partnership Fund for New York City; Alexandria Venture …

    Published on 6/20/2016
  • Spark Therapeutics completes follow-on

    Spark Therapeutics Inc. (NASDAQ:ONCE), Philadelphia, Pa. Business: Gene/Cell therapy, Ophthalmic, Hematology Date completed: 2016-06-14 Type: Follow-on Raised: $112.5 million Shares: 2.5 million Price: $45 Shares after …

    Published on 6/20/2016
  • Tonix completes follow-on

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), New York, N.Y. Business: Neurology, Musculoskeletal Date completed: 2016-06-16 Type: Follow-on Raised: $10 million Shares: 5 million Price: $2 Shares after offering: 25…

    Published on 6/20/2016
  • 1315 Capital LLC financial update

    1315 Capital LLC, Philadelphia, Pa. Business: Finance Date announced: 2016-06-15 Note: 1315 Capital closed its first fund at $200 million. The firm plans to invest in commercial-stage companies, including specialty …

    Published on 6/20/2016
  • Arkin Holdings financial update

    Arkin Holdings, Herzliya Pituach, Israel Business: Finance Date announced: 2016-06-16 Note: Arkin Holdings partnered with Israeli insurance company Phoenix Group (Tel Aviv:PHOE, Herzliya, Israel) to create Arkin Bio-…

    Published on 6/20/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993